Literature DB >> 11165254

beta-Adrenergic agonists increase phosphorylation of elongation factor 2 in cardiomyocytes without eliciting calcium-independent eEF2 kinase activity.

L E McLeod1, L Wang, C G Proud.   

Abstract

The beta-adrenergic agonist isoproterenol increased the phosphorylation of elongation factor eEF2 in ventricular cardiomyocytes from adult rats (ARVC). Phosphorylation of eEF2 inhibits its activity, and protein synthesis was inhibited in ARVC concomitantly with increased eEF2 phosphorylation. eEF2 kinase activity in ARVC extracts was completely dependent upon Ca(2+)/calmodulin. In contrast to other cell types, however, treatments designed to raise intracellular cAMP failed to induce Ca(2+)/calmodulin-independent activity. Instead, they increased maximal eEF2 kinase activity. Similar data were obtained when partially purified ARVC eEF2 kinase was treated with cAMP-dependent protein kinase in vitro. These data suggest that ARVC possess a distinct isoform of eEF2 kinase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165254     DOI: 10.1016/s0014-5793(01)02100-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Exercise rapidly increases eukaryotic elongation factor 2 phosphorylation in skeletal muscle of men.

Authors:  Adam J Rose; Christa Broholm; Kristian Kiillerich; Stephen G Finn; Christopher G Proud; Mark H Rider; Erik A Richter; Bente Kiens
Journal:  J Physiol       Date:  2005-10-06       Impact factor: 5.182

2.  Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.

Authors:  Artur Wnorowski; Mariola Sadowska; Rajib K Paul; Nagendra S Singh; Anna Boguszewska-Czubara; Lucita Jimenez; Kotb Abdelmohsen; Lawrence Toll; Krzysztof Jozwiak; Michel Bernier; Irving W Wainer
Journal:  Cell Signal       Date:  2015-02-20       Impact factor: 4.315

3.  Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability.

Authors:  Anne Beugnet; Andrew R Tee; Peter M Taylor; Christopher G Proud
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

4.  Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).

Authors:  Mark Rolfe; Laura E McLeod; Phillip F Pratt; Christopher G Proud
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

5.  A Ca(2+)-calmodulin-eEF2K-eEF2 signalling cascade, but not AMPK, contributes to the suppression of skeletal muscle protein synthesis during contractions.

Authors:  Adam J Rose; Thomas J Alsted; Thomas E Jensen; J Bjarke Kobberø; Stine J Maarbjerg; Jørgen Jensen; Erik A Richter
Journal:  J Physiol       Date:  2009-02-02       Impact factor: 5.182

6.  A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin.

Authors:  Gareth J Browne; Christopher G Proud
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

7.  The regulation of protein synthesis and translation factors by CD3 and CD28 in human primary T lymphocytes.

Authors:  Miranda Kleijn; Christopher G Proud
Journal:  BMC Biochem       Date:  2002-05-17       Impact factor: 4.059

8.  Coordination of changes in expression and phosphorylation of eukaryotic elongation factor 2 (eEF2) and eEF2 kinase in hypertrophied cardiomyocytes.

Authors:  Satoshi Kameshima; Muneyoshi Okada; Shiro Ikeda; Yuki Watanabe; Hideyuki Yamawaki
Journal:  Biochem Biophys Rep       Date:  2016-06-28

9.  Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist.

Authors:  Artur Wnorowski; Danuta Dudzik; Michel Bernier; Jakub Wójcik; Guido Keijzers; Alberto Diaz-Ruiz; Karolina Mazur; Yongqing Zhang; Haiyong Han; Morten Scheibye-Knudsen; Krzysztof Jozwiak; Coral Barbas; Irving W Wainer
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

10.  High-throughput screening of clinically approved drugs that prime nonviral gene delivery to human Mesenchymal stem cells.

Authors:  Tyler Kozisek; Andrew Hamann; Albert Nguyen; Michael Miller; Sarah Plautz; Angela K Pannier
Journal:  J Biol Eng       Date:  2020-05-19       Impact factor: 4.355

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.